Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
about
Mechanisms of Autoantibody-Induced Pathology.Antibodies against Apoptotic Cells Present in End-stage Lung Disease Patients Do Not Correlate with Clinical Outcome after Lung Transplantation.Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations.Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.Immediate and Catastrophic Antibody-Mediated Rejection in a Lung Transplant Recipient With Anti-Angiotensin II Receptor Type 1 and Anti-Endothelin-1 Receptor Type A Antibodies.
P2860
Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Anti-ETAR and anti-AT1R autoan ...... with endstage cystic fibrosis.
@en
Anti-ETAR and anti-AT1R autoan ...... with endstage cystic fibrosis.
@nl
type
label
Anti-ETAR and anti-AT1R autoan ...... with endstage cystic fibrosis.
@en
Anti-ETAR and anti-AT1R autoan ...... with endstage cystic fibrosis.
@nl
prefLabel
Anti-ETAR and anti-AT1R autoan ...... with endstage cystic fibrosis.
@en
Anti-ETAR and anti-AT1R autoan ...... with endstage cystic fibrosis.
@nl
P2093
P1476
Anti-ETAR and anti-AT1R autoan ...... with endstage cystic fibrosis.
@en
P2093
D A van Kessel
E A van de Graaf
J M Kwakkel-van Erp
T Hoefnagel
P356
10.1016/J.JCF.2014.07.007
P577
2014-08-02T00:00:00Z